07/28/2021 | Press release | Distributed by Public on 07/28/2021 12:16
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Sir Jonathan Symonds
|
|||
b)
|
Position/status
|
Non-Executive Chairman
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
£14.05
|
3,113.879
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Mr Charles Bancroft
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
$39.35
|
1,469.711
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Mr Vindi Banga
|
|||
b)
|
Position/status
|
Senior Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
£14.05
|
645.018
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Dr Anne Beal
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
$39.35
|
122.409
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Dr Vivienne Cox
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
£14.05
|
600.534
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Ms Lynn Elsenhans
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
$39.35
|
283.444
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Dr Laurie Glimcher
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
$39.35
|
1,049.794
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Dr Jesse Goodman
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
$39.35
|
346.432
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
||||
a)
|
Name
|
Mr Urs Rohner
|
|||
b)
|
Position/status
|
Independent Non-Executive Director
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GlaxoSmithKline plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b)
|
Nature of the transaction
|
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
|
|||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
||
£14.05
|
572.183
|
||||
d)
|
Aggregated information
|
N/A (single transaction)
|
|||
Aggregated volume
Price
|
|||||
e)
|
Date of the transaction
|
2021-07-28
|
|||
f)
|
Place of the transaction
|
N/A
|